Predicting pharmacokinetic herb-drug interactions

Area of Science:

• Pharmacology
• Pharmacokinetics
• Herbal Medicine Interactions

Background:

• Cytochrome P450 (CYP) enzyme induction or inhibition is a key mechanism in herb-drug interactions.
• Existing pharmacokinetic principles for drug-drug interactions can be adapted to predict herb-drug interactions.

Purpose of the Study:

• To predict pharmacokinetic herb-drug interactions using established drug-drug interaction principles.
• To evaluate the influence of various factors on the risk of herb-drug interactions.

Main Methods:

• Applied pharmacokinetic principles to model herb-drug interactions.
• Calculated expected AUC ratio based on unbound herbal inhibitor concentration ([I]), inhibition constant (Ki), hepatic fraction (fh), and metabolic pathway fraction (fm).
• Defined risk categories (low, medium, high) based on the summation of [Ii]/Ki(i).

Main Results:

• AUC ratio is primarily influenced by [I], Ki, fh, fm, and the number of inhibitory constituents (n).
• Risk stratification: low risk (<0.1), medium risk (0.1-1.0), and high risk (>1) based on sigma([Ii]/Ki(i)).
• For high clearance drugs, fh x fm changes had minimal impact; for low clearance drugs, fm was not a significant factor.

Conclusions:

• Predicting herb-drug metabolic interactions is feasible when key parameters ([I], Ki, fh, fm, n) are known.
• Prediction is complicated by numerous herb- and drug-related factors.
• Well-designed human studies are crucial for definitive interaction assessment.